Matthews International Reports Earnings for Fiscal 2017 Third Quarter
Jul 27, 2017 20:15 pm UTC| Business
GAAP EARNINGS PER SHARE OF $0.91, COMPARED TO $0.73 LAST YEARNON-GAAP EARNINGS PER SHARE OF $1.05, COMPARED TO $0.97 LAST YEAROPERATING CASH FLOW REMAINS STRONGINTEGRATIONS OF SGK AND AURORA REMAIN ON TRACK PITTSBURGH,...
Crown Castle to Present at the Cowen and Company 3rd Annual Communications Infrastructure Summit
Jul 27, 2017 20:15 pm UTC| Business
HOUSTON, July 27, 2017 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that Dan Schlanger, Crown Castle’s Chief Financial Officer, is scheduled to present on Tuesday, August 8, 2017 at...
Nevada Gold & Casinos Reports Fourth Quarter and Fiscal Year 2017 Results
Jul 27, 2017 20:15 pm UTC| Business
LAS VEGAS, July 27, 2017 -- Nevada Gold Casinos, Inc. (NYSE MKT:UWN) today announced financial results for the fourth quarter and year ended April 30, 2017. The Company will host a conference call today at 4:30 PM ET...
KEMET Continues to Expand its Industry-Leading High Voltage Multilayer Ceramic Capacitor Portfolio
Jul 27, 2017 20:15 pm UTC| Business
GREENVILLE, S.C., July 27, 2017 -- KEMET Corporation (NYSE:KEM), a leading global supplier of electronic components, today announced the expansion of its surface mount High Voltage Multilayer Ceramic Capacitor portfolio...
Jul 27, 2017 20:14 pm UTC| Business
Company Expects to Record Strongest Quarterly Revenues in History Kamada Expects to Report Full Financial Results for Second Quarter and Six Months Ended June 30, 2017, and Host Conference Call on August 1, 2017 ...
Jul 27, 2017 20:12 pm UTC| Business
WILMINGTON, Del., July 27, 2017 -- WSFS Financial Corporation (NASDAQ:WSFS), the parent company of WSFS Bank, reported net income of $20.6 million, or $0.64 per diluted common share for 2Q 2017 compared to net income of...
Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
Jul 27, 2017 20:12 pm UTC| Business
PRINCETON, N.J., July 27, 2017 -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the...